Annual Accounts Payable
$168.94 M
-$36.98 M-17.96%
30 December 2023
Summary:
Charles River Laboratories International annual accounts payable is currently $168.94 million, with the most recent change of -$36.98 million (-17.96%) on 30 December 2023. During the last 3 years, it has risen by +$46.46 million (+37.94%). CRL annual accounts payable is now -17.96% below its all-time high of $205.91 million, reached on 31 December 2022.CRL Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$135.96 M
+$2.86 M+2.15%
28 September 2024
Summary:
Charles River Laboratories International quarterly accounts payable is currently $135.96 million, with the most recent change of +$2.86 million (+2.15%) on 28 September 2024. Over the past year, it has dropped by -$378.00 thousand (-0.28%). CRL quarterly accounts payable is now -39.83% below its all-time high of $225.98 million, reached on 26 March 2022.CRL Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.0% | -0.3% |
| 3 y3 years | +37.9% | +6.3% |
| 5 y5 years | +155.0% | +26.8% |
CRL Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -18.0% | +37.9% | -39.8% | +13.3% |
| 5 y | 5 years | -18.0% | +155.0% | -39.8% | +63.9% |
| alltime | all time | -18.0% | +1718.3% | -39.8% | +1606.4% |
Charles River Laboratories International Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $135.96 M(+2.2%) |
| June 2024 | - | $133.10 M(+2.6%) |
| Mar 2024 | - | $129.68 M(-23.2%) |
| Dec 2023 | $168.94 M(-18.0%) | $168.94 M(+23.9%) |
| Sept 2023 | - | $136.34 M(-2.8%) |
| June 2023 | - | $140.20 M(+16.8%) |
| Mar 2023 | - | $120.00 M(-41.7%) |
| Dec 2022 | $205.91 M(+3.9%) | $205.91 M(+13.4%) |
| Sept 2022 | - | $181.63 M(-14.1%) |
| June 2022 | - | $211.38 M(-6.5%) |
| Mar 2022 | - | $225.98 M(+14.1%) |
| Dec 2021 | $198.13 M(+61.8%) | $198.13 M(+54.9%) |
| Sept 2021 | - | $127.91 M(+15.3%) |
| June 2021 | - | $110.93 M(-12.7%) |
| Mar 2021 | - | $127.13 M(+3.8%) |
| Dec 2020 | $122.47 M(+9.8%) | $122.47 M(+26.6%) |
| Sept 2020 | - | $96.76 M(+16.6%) |
| June 2020 | - | $82.98 M(-19.2%) |
| Mar 2020 | - | $102.70 M(-7.9%) |
| Dec 2019 | $111.50 M(+68.3%) | $111.50 M(+4.0%) |
| Sept 2019 | - | $107.23 M(+7.9%) |
| June 2019 | - | $99.38 M(+26.6%) |
| Mar 2019 | - | $78.52 M(+18.5%) |
| Dec 2018 | $66.25 M(-14.9%) | $66.25 M(-14.8%) |
| Sept 2018 | - | $77.74 M(+15.2%) |
| June 2018 | - | $67.48 M(-8.2%) |
| Mar 2018 | - | $73.48 M(-5.6%) |
| Dec 2017 | $77.84 M(+13.7%) | $77.84 M(+17.5%) |
| Sept 2017 | - | $66.23 M(+2.4%) |
| June 2017 | - | $64.65 M(+6.0%) |
| Mar 2017 | - | $60.99 M(-10.9%) |
| Dec 2016 | $68.48 M(+86.7%) | $68.48 M(+4.1%) |
| Sept 2016 | - | $65.81 M(-0.6%) |
| June 2016 | - | $66.20 M(+50.8%) |
| Mar 2016 | - | $43.90 M(+19.7%) |
| Dec 2015 | $36.67 M(+8.5%) | $36.67 M(+16.0%) |
| Sept 2015 | - | $31.63 M(-4.1%) |
| June 2015 | - | $32.97 M(-5.5%) |
| Mar 2015 | - | $34.90 M(+3.2%) |
| Dec 2014 | $33.81 M(+6.4%) | $33.81 M(+22.8%) |
| Sept 2014 | - | $27.55 M(-21.8%) |
| June 2014 | - | $35.22 M(-0.1%) |
| Mar 2014 | - | $35.25 M(+11.0%) |
| Dec 2013 | $31.77 M(+1.8%) | $31.77 M(+7.1%) |
| Sept 2013 | - | $29.68 M(-20.4%) |
| June 2013 | - | $37.30 M(+19.2%) |
| Mar 2013 | - | $31.28 M(+0.2%) |
| Dec 2012 | $31.22 M | $31.22 M(+12.5%) |
| Sept 2012 | - | $27.74 M(-19.6%) |
| June 2012 | - | $34.49 M(+6.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $32.35 M(-5.8%) |
| Dec 2011 | $34.33 M(+12.1%) | $34.33 M(-0.8%) |
| Sept 2011 | - | $34.62 M(+4.6%) |
| June 2011 | - | $33.09 M(-0.9%) |
| Mar 2011 | - | $33.38 M(+9.0%) |
| Dec 2010 | $30.63 M(-1.9%) | $30.63 M(-7.4%) |
| Sept 2010 | - | $33.07 M(+11.4%) |
| June 2010 | - | $29.68 M(-11.4%) |
| Mar 2010 | - | $33.51 M(+7.3%) |
| Dec 2009 | $31.22 M(-23.0%) | $31.22 M(-12.9%) |
| Sept 2009 | - | $35.84 M(-2.0%) |
| June 2009 | - | $36.57 M(-1.9%) |
| Mar 2009 | - | $37.28 M(-8.0%) |
| Dec 2008 | $40.52 M(+10.4%) | $40.52 M(+11.4%) |
| Sept 2008 | - | $36.37 M(-16.4%) |
| June 2008 | - | $43.52 M(+18.4%) |
| Mar 2008 | - | $36.77 M(+0.2%) |
| Dec 2007 | $36.72 M(+30.1%) | $36.72 M(+1.9%) |
| Sept 2007 | - | $36.01 M(+0.9%) |
| June 2007 | - | $35.71 M(-4.2%) |
| Mar 2007 | - | $37.26 M(+32.0%) |
| Dec 2006 | $28.22 M(-1.8%) | $28.22 M(+19.2%) |
| Sept 2006 | - | $23.68 M(-11.7%) |
| June 2006 | - | $26.81 M(-21.4%) |
| Mar 2006 | - | $34.13 M(+18.8%) |
| Dec 2005 | $28.73 M(+0.2%) | $28.73 M(+11.5%) |
| Sept 2005 | - | $25.75 M(+5.8%) |
| June 2005 | - | $24.35 M(-7.8%) |
| Mar 2005 | - | $26.40 M(-7.9%) |
| Dec 2004 | $28.67 M(+47.5%) | $28.67 M(+85.1%) |
| Sept 2004 | - | $15.49 M(-5.9%) |
| June 2004 | - | $16.45 M(+1.4%) |
| Mar 2004 | - | $16.23 M(-16.5%) |
| Dec 2003 | $19.43 M(+48.5%) | $19.43 M(+56.1%) |
| Sept 2003 | - | $12.45 M(-2.5%) |
| June 2003 | - | $12.77 M(+1.4%) |
| Mar 2003 | - | $12.59 M(-3.8%) |
| Dec 2002 | $13.08 M(-5.7%) | $13.08 M(+19.8%) |
| Sept 2002 | - | $10.92 M(-10.8%) |
| June 2002 | - | $12.24 M(+3.9%) |
| Mar 2002 | - | $11.78 M(-15.1%) |
| Dec 2001 | $13.87 M(+28.8%) | $13.87 M(+47.4%) |
| Sept 2001 | - | $9.41 M(-1.0%) |
| June 2001 | - | $9.50 M(-12.1%) |
| Mar 2001 | - | $10.81 M(+0.4%) |
| Dec 2000 | $10.77 M(+15.9%) | $10.77 M(+35.1%) |
| Sept 2000 | - | $7.97 M(-8.3%) |
| June 2000 | - | $8.69 M(-11.0%) |
| Mar 2000 | - | $9.77 M |
| Dec 1999 | $9.29 M(-20.0%) | - |
| Dec 1998 | $11.62 M | - |
FAQ
- What is Charles River Laboratories International annual accounts payable?
- What is the all time high annual accounts payable for Charles River Laboratories International?
- What is Charles River Laboratories International annual accounts payable year-on-year change?
- What is Charles River Laboratories International quarterly accounts payable?
- What is the all time high quarterly accounts payable for Charles River Laboratories International?
- What is Charles River Laboratories International quarterly accounts payable year-on-year change?
What is Charles River Laboratories International annual accounts payable?
The current annual accounts payable of CRL is $168.94 M
What is the all time high annual accounts payable for Charles River Laboratories International?
Charles River Laboratories International all-time high annual accounts payable is $205.91 M
What is Charles River Laboratories International annual accounts payable year-on-year change?
Over the past year, CRL annual accounts payable has changed by -$36.98 M (-17.96%)
What is Charles River Laboratories International quarterly accounts payable?
The current quarterly accounts payable of CRL is $135.96 M
What is the all time high quarterly accounts payable for Charles River Laboratories International?
Charles River Laboratories International all-time high quarterly accounts payable is $225.98 M
What is Charles River Laboratories International quarterly accounts payable year-on-year change?
Over the past year, CRL quarterly accounts payable has changed by -$378.00 K (-0.28%)